Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0001367644-21-000004

President and CEO sold 19,026 shares at $106.01 ($2,016,901)

  • President and CEO acquired 19,026 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kramer Robert President and CEO 2021-01-15 Option exercise +19,026 $25.62 $487,446 158,236 D: show line 1 in the form
Kramer Robert President and CEO 2021-01-15 Sale −19,026 $106.01 $2,016,901 139,210 D: show line 2 in the form
Open-market sales · 19,026 sh · avg $106.01 · $2,016,901

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kramer Robert President and CEO 2021-01-15 Option exercise · Employee Stock Options (Right to Buy) −19,026 0 D: show line 3 in the form
Loading xslF345X03/wf-form4_161109171024831.xml…